1.11
price down icon1.77%   -0.02
after-market Handel nachbörslich: 1.12 0.01 +0.90%
loading

Finanzdaten der Pliant Therapeutics Inc-Aktie (PLRX)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-06-30 2025-03-31 2024-09-30 2024-06-30 2024-03-31
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
-
- - - -
Operating Expenses
22.64%
45.59
58.94 62.01 60.64 52.39
Operating Income/Loss
22.64%
-45.59
-58.94 -62.01 -60.64 -52.39
Income/Loss From Continuing Operations Before Tax
22.91%
-43.30
-56.17 -57.76 -55.85 -46.95
Income Tax Expense/Benefit
-
- - - -
Income/Loss From Continuing Operations After Tax
22.91%
-43.30
-56.17 -57.76 -55.85 -46.95
Net Income/Loss
22.91%
-43.30
-56.17 -57.76 -55.85 -46.95
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
0.27%
61.39
61.22 60.73 60.38 60.18
Diluted Average Shares
0.27%
61.39
61.22 60.73 60.38 60.18
Basic Earnings Per Share
22.83%
-0.71
-0.92 -0.95 -0.92 -0.78
Diluted Earnings Per Share
22.83%
-0.71
-0.92 -0.95 -0.92 -0.78
Common Stock Dividends
-
- - - -
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$26.45
price down icon 1.12%
$45.19
price up icon 0.87%
$101.10
price up icon 0.35%
$105.87
price up icon 0.10%
$148.75
price up icon 1.77%
biotechnology ONC
$346.07
price down icon 0.10%
Kapitalisierung:     |  Volumen (24h):